Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2024-12-02 00:00:00 ET · period of report 2024-12-02 · accession 0000950170-24-132401 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-12-02 | 2024-12-02 | KYMR | Esposito Pamela | Dir | M - OptEx | $29.55 | +2,500 | 2,500 | New | +$73.9K |
| DT | 2024-12-02 | 2024-12-02 | KYMR | Esposito Pamela | Dir | S - Sale+OE | $49.00 | -2,500 | 0 | -100% | -$122.5K |
| DT | 2024-12-02 | 2024-12-02 | KYMR | Esposito Pamela | Dir | M - OptEx | $0.00 | -2,500 | 29.1K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-02 | M | A | 2,500 | $29.55 | 2,500 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-02 | S | D | 2,500 | $49.00 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-12-02 | M | D | 2,500 | $0.00 | 29,127 | D | $29.55 · — to 2030-09-03 | 2,500 Common Stock | (F2) The shares underlying this stock option are fully vested and exercisable. |